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Abstract
We previously reported that a bi-phasic innate immune MAPK response, constituting activation of the mitogen-activated
protein kinase (MAPK) phosphatase MKP1 and c-Fos transcription factor, discriminates between the yeast and hyphal forms
of Candida albicans in oral epithelial cells (ECs). Since the vast majority of mucosal Candida infections are vaginal, we sought
to determine whether a similar bi-phasic MAPK-based immune response was activated by C. albicans in vaginal ECs. Here,
we demonstrate that vaginal ECs orchestrate an innate response to C. albicans via NF-kB and MAPK signaling pathways.
However, unlike in oral ECs, the first MAPK response, defined by c-Jun transcription factor activation, is delayed until 2 h in
vaginal ECs but is still independent of hypha formation. The ‘second’ or ‘late’ MAPK response, constituting MKP1 and c-Fos
transcription factor activation, is identical to oral ECs and is dependent upon both hypha formation and fungal burdens. NF-
kB activation is immediate but independent of morphology. Furthermore, the proinflammatory response in vaginal ECs is
different to oral ECs, with an absence of G-CSF and CCL20 and low level IL-6 production. Therefore, differences exist in how
C. albicans activates signaling mechanisms in oral and vaginal ECs; however, the activation of MAPK-based pathways that
discriminate between yeast and hyphal forms is retained between these mucosal sites. We conclude that this MAPK-based
signaling pathway is a common mechanism enabling different human epithelial tissues to orchestrate innate immune
responses specifically against C. albicans hyphae.
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Introduction
The mucosal epithelium is of immense importance in host
defense and immune surveillance, as it is the initial tissue
encountered by the majority of infecting microorganisms. Vaginal
epithelium provides a physical barrier, which recognizes com-
mensal and pathogenic microbes, as well as regulating the influx of
immune cells to prevent inflammatory tissue destruction. This
specialized interaction between microbes, epithelial cells (ECs) and
local immune cells results in either a degree of mutualism between
microbe and host, as in the case of commensal microbes, or a
breach of the mucosal barrier and subsequent cell injury, as in the
case of pathogenic microbes. Indeed, the integrity of the host
immune system plays an important role in defining whether a
microbe acts as a commensal colonizer or as an opportunistic
pathogen. Of particular interest are ‘opportunistic’ microbes,
which although normally commensal are capable of becoming
pathogenic. The polymorphic fungus Candida albicans is one such
opportunistic microbe, being a constituent of the normal vaginal
microbiota but commonly causing mucosal disease in healthy
women of fertile age [1].
Recently, we identified a host mechanism in oral ECs that
discriminates between the commensal and pathogenic states of C.
albicans, which is based on hypha recognition and fungal burdens
[2]. We demonstrated that epithelial innate immunity against C.
albicans is initiated via NF-kB and a bi-phasic mitogen-activated
protein kinase (MAPK) response. Activation of NF-kB and the first
MAPK phase, constituting activation of the c-Jun transcription
factor, is independent of morphology and is due to the recognition
of fungal cell wall polysaccharides (chitin, mannan, b-glucan).
Activation of the second MAPK phase, constituting phosphory-
lation of the MAPK phosphatase MKP1 and activation of the c-
Fos transcription factor, is specifically induced by C. albicans
hyphae and correlates with proinflammatory responses and cell
damage in a dose-dependent manner. This proinflammatory
response is thought to recruit neutrophils and protects against oral
fungal infection via a novel mechanism involving epithelial toll-like
receptor (TLR) 4 [3]. However, neutrophil recruitment at the
vaginal mucosa is thought to be detrimental to the host [4] and
does not necessarily result in clearance of the fungal infection,
demonstrating fundamental immunological differences in respons-
es to C. albicans at these two mucosal sites.
Given our findings in oral ECs, in this study we sought to
determine how C. albicans activates vaginal ECs and whether a
similar MAPK/MKP1/c-Fos discriminatory system also exists,
with the aim of potentially identifying a common mechanism
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1enabling different epithelial tissues to identify when this normally
commensal fungus switches to hyphal growth associated with
invasion and pathology.
Materials and Methods
Cell lines, reagents and Candida albicans strains
Experiments were carried out using the A431 human vulval
epidermoid carcinoma cell line and the TR146 buccal epithelial
carcinoma cell line (SkinEthic Laboratories, Nice, France).
Monolayer epithelial cultures were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM) (PAA, UK) supplemented with 10%
fetal bovine serum (FBS) (PAA, UK) and experiments carried out
in serum-free DMEM. Reconstituted human vaginal epithelium
(vaginal RHE: 5-day) were purchased from SkinEthic Laboratories
(Nice, France) and used as previously described [2,5]. This model
is created from the same cell line (A431) and constitutes several
layers of stratified squamous epithelium permitting the direct
analysis of pathogen-epithelial interactions that are not compli-
cated by non-epithelial factors. Antibodies to phospho-p38,
phospho-ERK1/2, phospho-JNK, phospho-MKP1, phospho-
IkBa,I kBa and c-Fos were purchased from Cell Signalling
Technologies (New England Biolabs, UK). Mouse monoclonal
antibody to human a-actin was purchased from Chemicon
(Millipore) and goat anti-mouse and anti-rabbit horseradish
peroxidase (HRP)-conjugated antibodies were purchased from
Jackson Immunologicals Ltd (Stratech Scientific, UK). Fungal
strains included C. albicans wild-type SC5314 [6], CAI4 (+CIp10)
(NGY152) [7], Dnrg1 (MMC4) [8] and Defg1/cph1 (Can36) [9]. All
strains were grown in YPD medium (1% Yeast Extract, 2%
Peptone, 2% Dextrose) overnight at 30uC to stationary phase prior
to experimentation.
Fungal infection of epithelium
C. albicans strains were inoculated at 2610
6 cells after being
washed twice in sterile PBS onto vaginal RHE, or between10
4–7
cells/ml for signaling assays and cytokine assays on monolayer
epithelial cultures. The multiplicity of infection (MOI) ranged
from 0.01–10 (fungal cells per EC) depending on the experiment.
Vaginal RHE and monolayers were incubated at 37uCi n5 %C O 2
for 5, 15, 30, 60 min, 2, 3 or 24 h as previously described [2,5,10]
depending on the experiment. Non-infected controls contained
PBS alone.
Western blotting
ECs were lysed using a modified RIPA lysis buffer (50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton x-100,
1% Sodium deoxycholate, 0.1% SDS) containing protease (Sigma-
Aldrich) and phosphatase inhibitors (Perbio), left on ice for
30 min, and then centrifuged for 10 min in a refrigerated
microfuge. Supernatants were assayed for total protein using the
BCA protein quantitation kit (Perbio). 20 mg of protein was
separated on 12% SDS-PAGE gels before transfer to PVDF
membranes (GE Healthcare, UK). After probing with primary and
secondary antibodies (dilutions vary from 1:1000 to 1:10,000),
membranes were developed using Immobilon chemiluminescent
substrate (Millipore, UK) and exposed to ECL film (GE
Healthcare, UK). a-actin was used as a loading control.
Transcription factor DNA binding assay
c-Fos DNA binding activity was assessed using the TransAM
transcription factor ELISA system (Active Motif, Belgium). Briefly,
nuclear proteins were isolated from ECs after 3 h infection with C.
albicans using a nuclear protein extraction kit as per manufacturer’s
instructions (Active Motif, Belgium). Protein concentration was
determined as above and 5 mg of nuclear extract was assayed in
the TransAM system according to the manufacturer’s protocol.
Cytokine determination
Cytokine levels (IL-1a, IL-6, IL-8, G-CSF, GM-CSF, TNFa,
MCP-1 (CCL2) and MIP-1a (CCL3)) in cell culture supernatants
were determined at 24 h using the Fluorokine MAP cytokine
multiplex kits (R&D Systems), coupled with the Luminex 100
TM
machine according to the manufacturer’s protocol. The trimmed
median value was used to derive the standard curve and calculate
sample concentrations. Standard curve ranges were as follows: IL-
1a 1,850 pg/ml – 2.5 pg/ml; IL-6 4,950 pg/ml – 6.8 pg/ml; IL-8
2,950 pg/ml – 4 pg/ml; G-CSF 4,500 pg/ml – 6.2 pg/ml; GM-
CSF 2,850 – 3.9 pg/ml. CCL20 (MIP-3a) was analyzed using the
Duoset ELISA kit (R&D Systems) and standard curve range was
1,000 pg/ml – 15.6 pg/ml. Values for both assays were only
regarded as valid if they fell within the standard curve range.
Epithelial cell damage assay
EC damage was determined at 24 h by measuring lactate
dehydrogenase (LDH) activity in the culture supernatant as
described previously [2,5,10]. This was performed using the
Cytox 96 Non-Radioactive Cytotoxicity Assay kit (Promega)
according to the manufacturer’s protocol and using a recombinant
porcine LDH (Sigma-Aldrich) to generate a standard curve.
Sample values were then extrapolated from this curve.
Immunohistochemistry of vaginal RHE
C. albicans infected vaginal RHE was fixed in 10% (v/v) formal-
saline before being embedded and processed in paraffin wax using
standard protocol. 5 mm sections were prepared using a Leica
RM2055 microtome and silane coated slides. After dewaxing in
xylene, protein expression was determined using rabbit anti-
human polyclonal antibodies for MKP1 (Santa Cruz Biotechnol-
ogy) and c-Fos (Source Bioscience) (1:10 and 1:100, respectively)
and counterstained with peroxidase-conjugated goat anti-rabbit
secondary IgG antibody, followed by diaminobenzidine (DAB)
chromogen detection as per manufacturer’s protocol. To visualize
C. albicans, sections were stained using Periodic Acid Schiff (PAS),
counterstained with haematoxylin and examined by light micros-
copy.
Statistics
Data were analyzed in the GraphPad software package using
either the unpaired two tailed t-test or in the case of hyphae vs.
yeast cytokine comparisons, ANOVA with Bonferroni post-hoc
analysis. In all cases, p,0.05 was taken to be significant.
Results
Activation of the NF-kB and MAPK signaling pathways
A431 vaginal ECs were infected with C. albicans SC5314 and
IkB-a phosphorylation, which is a key event in NF-kB pathway
activation, and ERK1/2, JNK and p38 phosphorylation (MAPK
activation) was determined after 5, 15, 30, 60 and 120 min (5 min
not performed for IkB-a). Immunoblot analysis confirmed that
IkB-a phosphorylation occurs immediately, being detectable
15 min post-infection, and persists over a 2 h period (Fig. 1A).
Interestingly, there was a lack of JNK and p38 phosphorylation
and only a slight increase in the phosphorylation of ERK1/2 at
early time points (5–60 min) but strong activation of all three
MAPK proteins at 2 h post-infection (Fig. 1B). We next explored
downstream MAPK-induced events by investigating MKP1
Vaginal Epithelial Signaling against Candida
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negative feedback loop regulating the MAPK pathway [11] and is
phosphorylated by ERK1/2 to prevent its degradation. This event
is independent of gene transcription and is mediated by ERK1/2
[12]. Phosphorylation of MKP1 only appeared at 2 h post-
infection (Fig. 1B), coinciding with phosphorylation of the three
MAPK proteins. In summary, in vaginal ECs the early MAPK
response against C. albicans appears to be absent but the late
MAPK response is activated culminating in stabilization of MKP1.
Activation of MAPK transcription factors
MAPK signaling is associated with activation of the AP-1
transcription factor complex, which is a heterodimer of a Jun
family member (JunB, JunD, c-Jun) and a Fos family member
(Fra1, Fra2, c-Fos, and FosB) [13,14]. Given the temporal
differences we observed in MAPK activation between vaginal
ECs (Fig. 1B) and oral ECs [2], we determined changes in DNA
binding activity (and thus activation) of all AP-1 family members
30 min and 3 h post-infection with C. albicans, which were
previously determined as optimal time points in oral ECs to
measure DNA binding activity [2]. In resting vaginal ECs, DNA
binding activity is present for all members of the Jun and Fos
families (Fig. 2A). Interestingly, whilst no changes in AP-1
transcription factor binding was observed at 30 min post-infection
(early response), by 3 h both c-Jun and c-Fos binding was
significantly increased compared with the PBS control (p,0.05)
(Fig. 2B). This activity at the transcription factor level (c-Jun and c-
Fos) parallels activation of the MAPK response at the signal
pathway level (Fig. 1B). The binding activity of other Jun or Fos
proteins at 3 h was unaltered (data not shown). As well as the AP-1
family, we investigated the binding activity of other MAPK-
induced transcription factors, including c-Myc, ATF2, Elk-1, and
MEF2. Elk-1 DNA binding activity mirrored c-Jun DNA binding
activity in that there was no change at 30 min but was increased at
3h( p ,0.05) (Fig. 2B). In contrast, MEF2 DNA binding activity
also showed no change at 30 min but was decreased at 3 h
(p,0.05) (Fig. 2B). DNA binding activity of ATF2 and c-Myc was
unchanged at both time points (data not shown). The data
demonstrate that vaginal ECs direct a specific and organized
response to C. albicans, whereby changes in transcription factor
binding activity occurred at 3 h post-infection, with distinct
profiles of activity that either mirror (c-Fos increased and MEF2
decreased) or differ (c-Jun increased at 3 h, Elk-1 increased at 3 h,
not decreased at 2 h) from those seen in oral ECs.
Vaginal and oral cytokine profiles differ
MKP1 and c-Fos activation correlates with cytokine production
in response to C. albicans infection in oral ECs [2]. Therefore, we
hypothesized that C. albicans infection would also induce cytokine
production in vaginal ECs. A431 monolayers were infected with C.
albicans at an MOI of 0.01 (this having previously been determined
as the optimal ratio of fungal cells for a 24 h infection study [2].
Analysis of culture supernatants of A431 epithelial monolayers
24 h post-infection with C. albicans SC5314 demonstrated that of
the nine cytokines and chemokines assessed (IL-1a, IL-6, IL-8, G-
CSF, GM-CSF, TNFa, MCP-1 (CCL2), MIP-1a (CCL3) and
MIP-3a (CCL20)), only three were significantly induced by C.
albicans: IL-1a, IL-8 and GM-CSF, with IL-6 induced in very low
amounts, although still showing a 4-fold increase over resting cells
(Fig. 3A). As with oral ECs, C. albicans induces significant damage
to vaginal ECs after 24 h as measured by LDH release (Fig. 3B)
with a concurrent release of the damage-associated cytokine IL-1a
(Fig. 3A). Since C. albicans infection of oral ECs induces additional
cytokines including G-CSF and CCL20 [2,15]), we re-assessed the
oral TR146 ECs cytokine response and compared this with the
A431 vaginal ECs cytokine response. Fig. 3C confirms the absence
of CCL20, very low level of G-CSF, and low level IL-6 secretion
by A431 vaginal ECs as compared with TR146 oral ECs.
c-Fos activation and cytokine production is dependent
on C. albicans morphology
C. albicans infection of vaginal ECs results in yeast-to-hyphal
transition by 1 h. Therefore, we hypothesized that epithelial
activation might be due to a specific response to hypha formation,
just like in oral ECs [2]. To test this, we infected A431 cells with C.
albicans SC5314 and two mutants strains,Defg1/cph1 (unable to
form hyphae) and Dnrg1 (hyperfilamentous), for 30 min and 2 h
and tested for induction of the two transcription factors associated
with the bi-phasic MAPK-based response in oral ECs: c-Fos
(specific response to hyphae) and c-Jun (general response to C.
albicans). Furthermore, because in vaginal ECs c-Jun phosphory-
lation was part of the late (2 h) MAPK-mediated response (Fig. 1B)
(when hypha formation is evident), we wanted to determine
whether c-Jun phosphorylation was hypha-dependent or just a
Figure 1. C. albicans infection of A431 epithelial cells activates
NF-kB and MAPK signaling. C. albicans SC5314 was added to A431
vaginal ECs under standard culture conditions for 5, 15, 30, 60 min and
2 h. Total protein was isolated and phosphorylation of (A) IkBa or (B)
p38, JNK, ERK1/2 and MKP1 were assessed by Western blotting. Bands
are shown with an a-actin loading control. A C. albicans:EC MOI of 10:1
was used. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0026580.g001
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independent). The respective morphological phenotypes of these
mutants were maintained throughout all experiments.
c-Fos was not induced at either time point by the Defg1/cph1
non-filamentous mutant but was induced at 2 h by the Dnrg1
hyperfilamentous mutant, albeit less than the wild-type C. albicans
SC5314 (Fig. 4A), confirming that c-Fos induction in vaginal ECs
is also dependent on hypha formation. The difference between
Dnrg1 and SC5314 can be explained partly by the reduced level of
adherence of Dnrg1 as compared with SC5314 and partly by the
lack of fungal-EC contact i.e. the SC5314 cells settled rapidly onto
the epithelial surface prior to hypha formation whereas the Dnrg1
hyperfilamentous strain ‘floated’ for a prolonged period of time
before gradually settling, thus reducing the MOI and threshold
level of activation [2]. Notably, all three C. albicans strains
phosphorylated c-Jun at 2 h but not at 30 min (Fig. 4A),
demonstrating that c-Jun phosphorylation appears to be indepen-
dent of hypha formation i.e. is a delayed general response to C.
Figure 2. Activation of MAPK transcription factors by C. albicans in A431 vaginal epithelial cells. (A) Resting levels of DNA binding activity
(absorbance values) of AP-1 transcription factor members in nuclear extracts from A431 ECs, measured by TransAm ELISA. (B) Changes in DNA
binding activity of c-Jun, Elk1, c-Fos, and MEF2 in nuclear extracts of A431 ECs 30 and 180 min post-infection with C. albicans SC5314 by TransAm
ELISA. These MAPK-activated transcription factors have previously been identified as showing altered DNA binding activity in oral ECs. Data are
represented as fold change relative to resting levels at 0 h. A C. albicans:EC MOI of 10:1 was used. Data represent mean values 6 SEM and are
representative of a minimum of three independent experiments. Statistical analysis (B) of raw data for infected versus uninfected cells was performed
using the unpaired, two-tailed t-test * p,0.05.
doi:10.1371/journal.pone.0026580.g002
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cytokine production we wanted to confirm that the hypha
deficient strain was unable to induce cytokines since it was unable
to induce c-Fos. Figure 4B confirms that the non-filamentous
strain (Defg1/cph1) failed to induce cytokine production, whereas
the hyperfilamentous strain (Dnrg1) was able to induce IL-1a, IL-6
Figure 3. Cytokine activation and cell damage induced by C. albicans in A431 vaginal epithelial cells and TR146 oral epithelial cells.
(A) C. albicans SC5314 was added to monolayers of A431 ECs for 24 h and the cell culture medium collected and assessed for cytokine proteins by
multiplex microbead assay (luminex) or ELISA (CCL20). (B) LDH (lactate dehydrogenase) release (measure of cell damage) from A431 ECs 24 h post-
infection with C. albicans SC5314. (C) Comparison of cytokine protein release by A431 ECs and TR146 ECs 24 h post-infection with C. albicans SC5314.
A C. albicans:EC MOI of 0.01 was used for all the experiments. Data are mean values 6 SEM of three independent experiments. Statistical analysis of
infected versus uninfected epithelial cells (A & B) or oral versus vaginal epithelial cells (C) was performed using the unpaired, two-tailed t-test.
*p ,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0026580.g003
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probably for the reasons stated above. Since Defg1/cph1 was able to
induce c-Jun activation (Fig. 4A) but was unable to induce
cytokines (Fig. 4B), this suggests that c-Jun does not contribute to
cytokine production. Together, the data indicate that in vaginal
ECs c-Fos activation is hypha specific and is required for cytokine
production, whereas c-Jun activation is delayed, independent of
hypha formation and does not contribute to cytokine induction.
MAPK/MKP1/c-Fos response is dependent on fungal
burden
Activation of the MAPK/MKP1/c-Fos response in oral ECs is
dependent on fungal burden, which may represent a danger
response that is only activated if sufficient C. albicans hyphae are
present [2]. To determine whether a similar threshold level of
activation is required in vaginal ECs, we stimulated A431 cells
with different doses of C. albicans SC5314 (10
4–10
7 cells/ml). This
was equivalent to an MOI of 0.01–10 C. albicans cells per EC.
Interestingly, induction of MKP1 and c-Jun phosphorylation and
c-Fos were observed only at the highest MOI of 10 (Fig. 5), which
is a log greater than oral ECs [2].
MKP1 and c-Fos activation in an RHE model of vaginal
epithelium
Finally, to obtain more in vivo relevant data, we determined the
presence of MKP1 and c-Fos expression in RHE models of human
vaginal epithelium after 3, 6, 12 and 24 h post-infection with C.
albicans SC5314. c-Jun was not investigated as c-Jun activation was
not hypha-dependent or associated with epithelial activation (see
data above). Figure 6 shows a gradual intensification of MKP1 and
c-Fos expression (brown staining) as time proceeds from 3–24 h
post-infection. Expression can be observed in regions of hyphal
contact moving from the surface at early time points (3 h) to
deeper epithelial layers at later time points (24 h). A clear
delineation can be observed with cells in contact with hyphae
showing expression of both MKP1 and c-Fos, whilst cells in
adjacent uninfected areas show little increase in MKP1 and c-Fos
expression.
Discussion
Discrimination between the yeast and hyphal form of C. albicans
appears to be a crucial event for epithelial immune activation and
fungal pathogenicity [2,5,16,17]. Previously, we demonstrated that
oral ECs initiate innate immunity against C. albicans via a bi-phasic
MAPK response. MAPK activation is key to hypha discrimination
and constitutes phosphorylation of the MAPK phosphatase
MKP1, activation of the c-Fos transcription factor, and induction
Figure 4. Induction of c-Jun phosphorylation, c-Fos and
cytokine production in A431 vaginal epithelial cells is depen-
dent on C. albicans hypha formation. (A) C. albicans SC5314 (wild
type), CAI4 (parent control), Defg1/cph1 (non-filamentous) and Dnrg1
(hyperfilamentous) were added to A431 vaginal ECs under standard
culture conditions for 30 min and 2 h. Total protein was isolated and
induction of c-Jun phosphorylation and c-Fos assessed by Western
blotting. Bands are shown alongside an a-actin loading control. (B)
Cytokine protein production by A431 ECs 24 h post-infection with all
four strains as measured by multiplex microbead assay (luminex). A C.
albicans:EC MOI of 10:1 (A) and 0.01 (B) was used. Data are
representative (A) or mean 6 SEM (B) of three independent
experiments. Statistical analysis (B) of SC5314, CAI-4, Defg1/cph1 and
Dnrg1 infected versus PBS-treated controls was performed using the
ANOVA test with Bonferroni post-hoc analysis. ***=p,0.001.
doi:10.1371/journal.pone.0026580.g004
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differences exist in how vaginal ECs initially respond to C. albicans
as compared with oral ECs, but that a near-identical MAPK-based
mechanism discriminates between the yeast and hyphal form of C.
albicans. We propose that this MAPK/MKP1/c-Fos-based signal-
ing system identifies a common mechanism playing a central role
in enabling different human epithelial tissues to recognize C.
albicans hyphae and initiate innate immune responses.
We found that NF-kB responses in vaginal ECs are the same as
for oral ECs, indicating that this would appear to be a generic EC
response to C. albicans. In contrast, the pattern of MAPK activation
in vaginal ECs differs from oral ECs. Although the hyphal
discrimination response (c-Fos and MEF2 DNA binding activity
and MKP1 phosphorylation) is identical in both cell types, there
are major differences in the generic Candida recognition response
(c-Jun activation/phosphorylation). Unlike oral ECs, vaginal ECs
show a delayed response (2 h instead of 30 min). As well as the
delay in activation, Elk-1 also shows an increase rather than the
decrease in activity seen in oral ECs. This data suggested one of
two possibilities. Either the early MAPK response to the yeast
form is ‘delayed’ but still occurs at later time points coinciding with
the hyphal-mediated activation of MKP1 and c-Fos, or vaginal
ECs are unresponsive to the yeast form via the MAPK pathways
and respond only to the hyphal form to activate both c-Jun and c-
Fos. However, the C. albicans hyphal deficient strain (Defg1/cph1)
was able to induce c-Jun phosphorylation but not c-Fos at 3 h
whilst the hyperfilamentous strain (Dnrg1) induced both c-Jun and
c-Fos. This indicates that c-Fos activation in vaginal ECs is hypha
specific, whereas c-Jun activation is a delayed response to C.
albicans yeast and independent of hypha formation. We then
assessed induction of the hypha-associated response by analysing
MKP1 and c-Fos expression in an RHE model of vaginal infection
and found a gradual intensification of MKP1 and c-Fos expression
as C. albicans infection progressed. This confirmed the association
of MKP1 and c-Fos induction with hypha formation. From these
data we conclude that (i) initial recognition of C. albicans yeasts in
vaginal ECs is mediated solely by the NF-kB pathway, whereas in
oral ECs it is mediated by both NF-kB and MAPK pathways, and
(ii) both c-Jun and c-Fos transcription factors are activated in
vaginal ECs in the late MAPK response to C. albicans whereas only
c-Fos is activated in oral ECs, but in both EC types only c-Fos
activation is hypha specific.
Of major importance is the finding that this MAPK/MKP1/c-
Fos response mechanism is dependent not only on hypha
formation but also on fungal burdens and suggests that a threshold
level of stimulation is required prior to full activation of the
epithelial innate response. This may provide a mechanism by
which epithelial tissues can remain quiescent in the presence of low
fungal burdens (even if hyphae are present) whilst responding
specifically and strongly to damage-inducing hyphae as burdens
increase. However, of particular interest was the finding that
induction of MKP1 and c-Jun phosphorylation and c-Fos was
observed only at the highest MOI of 10, one log greater than in
oral ECs [2]. This indicates that the responsiveness of vaginal ECs
to C. albicans is lower than that of oral ECs and that vaginal ECs
may be able to tolerate greater fungal (hyphal) burdens before
epithelial activation is initiated. The importance of this difference
in fungal burdens to immunity at these two surfaces can be seen
more clearly when responses in vivo to candidiasis is considered. In
oral mucosa, neutrophils play an important role in clearing or
combating infections by C. albicans. However, the situation in
vaginal mucosa may be different, where neutropenia does not have
a major impact on Candida burdens but does result in reduced
inflammation [18,19]. Importantly, vaginal ECs have a direct
fungistatic effect that does not require EC viability, thus
controlling the burden of C. albicans without recourse to
neutrophils or other immune cells [20–23]. With the discovery
that women with infrequent or recurrent vulvovaginal candidiasis
show symptomatic disease at correspondingly lower Candida
burdens [4] and that this increased sensitivity is due to EC
responsiveness, we can hypothesize that vaginal ECs play a key
role in managing Candida burdens at vaginal mucosal surfaces,
Figure 5. Effect of fungal burdens on MKP1, c-Fos and c-Jun
activation. A431 vaginal ECs were infected for 2 h with C. albicans
SC5314 at MOI’s ranging between 0.01 and 10. Total protein was
isolated and phosphorylation of MKP1 and c-Jun and c-Fos induction
was assessed by Western blotting. Bands are shown alongside an a-
actin loading control. Data are representative of four independent
experiments.
doi:10.1371/journal.pone.0026580.g005
Figure 6. Expression of MKP1 and c-Fos in vaginal RHE. Increase
in MKP1 and c-Fos expression in vaginal epithelium is associated with C.
albicans SC5314 hypha formation, with minimal activation at the
surface by 3 h and gradually increased activation co-localising in the
epithelial layers where hyphae penetrate and invade at 6, 12 and 24 h
(dark brown staining). Resting levels of MKP1 and c-Fos expression can
be seen in areas without C. albicans at each time point (sectional
control).
doi:10.1371/journal.pone.0026580.g006
Vaginal Epithelial Signaling against Candida
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e26580controlling fungal burden in a passive manner but driving
pathological inflammation when they become activated. This
inflammation is driven by the recruitment of neutrophils by ECs,
which may result in uncontrolled inflammation [24].
Although the initial recognition of C. albicans yeast cells appears
to be via NF-kB, this does not necessarily result in immunostim-
ulation as the hyphal deficient strain Defg1/cph1 was unable to
induce cytokines after 24 h despite activating NF-kB. This lack of
cytokine induction by C. albicans yeast cells is common to oral ECs
[2] but is in contrast to myeloid/lymphoid cells where strong
cytokine responses are induced by yeast cells [25–27]. Similar
effects have been reported in gut ECs, where both NF-kB and p38
signaling are required for full activation of inflammation in the gut
[28]. In contrast, wild-type C. albicans and the hyperfilamentous
strain Dnrg1 induced cytokine secretion (IL-1a, GM-CSF and IL-6)
in vaginal ECs, which correlated with induction of MAPK
pathways, MKP1 phosphorylation and c-Fos activation. Our
combined data indicate that ECs from different mucosal sites (oral
and vaginal) respond to C. albicans differently to that of myeloid/
lymphoid cells by specifically targeting the hyphal form of the
fungus, which leads to differential cytokine production. We note
that the shift in morphology from yeast to hyphae results in the
expression of many different potential virulence factors, such as
secreted aspartyl proteases (Saps) and adhesins and it may be that
the lack of vaginal EC responses to the hyphal deficient strain
Defg1/cph1 is partly due to the lack of production of such virulence
factors. The identities of the hyphal moieties or surface EC
receptors that induce/mediate vaginal epithelial activation are
currently unknown but will be the focus of future studies.
Cytokine induction was dependent upon hypha formation
correlating with c-Fos activation, MKP1 stabilization and cell
damage. Like in oral ECs, we propose that activation of this
MAPK-based response represents a ‘danger response’ mechanism
informing the host of invading hyphae. Interestingly, the cytokines
secreted by vaginal ECs in response to C. albicans differed to the
cytokines secreted by oral ECs, despite the same signaling pathways
being activated (NF-kB and MAPK). We and others have shown that
oral EC’s secrete IL-1a, IL-6, GM-CSF, G-CSF, IL-8 and CCL20
[2,3,29,30], whereas vaginal ECs only secreted IL-1a,I L - 8a n dG M -
CSF (this study: IL-6 is released but at very low levels compared with
oral ECs). This suggests that although a common signaling
recognition system is utilized by both EC lineages to detect C.
albicans, downstream induction of immune effector responses can
differ, demonstrating that a further level of immunoregulation
probably exists at latter stages of EC activation. Given the established
linkbetweenIL-1aand celldamage [31,32], the secretion of IL-1aby
both oral and vaginal ECs is probably the resultof hypha-induced cell
damage. IL-8 and GM-CSF secretion by both EC types will function
to recruit and activate neutrophils to the site of mucosal infection,
which is a well established phenomenon [33].
The potential importance in vivo of why IL-6, G-CSF and
CCL20 are selectively induced by C. albicans in oral ECs but not
vaginal ECs is not known. IL-6 can act as both a pro-inflammatory
and anti-inflammatory cytokine and G-CSF stimulates the
proliferation, differentiation and function of neutrophils. Neutro-
phil recruitment to vaginal tissues during candidiasis occurs in
humans [4] and mice [24]. However, in humans, neutrophil
recruitment appears to have a detrimental effect, resulting in acute
inflammation and thus symptoms associated with vaginitis [4]. In
contrast, recruitment of neutrophils in human oral Candida
infection is regarded as beneficial [34,35] and has been shown
to protect against infection in an RHE model of oral candidiasis
[3]. In addition, neutropenic patients are susceptible to oropha-
ryngeal candidiasis [36]. It is possible that the lack of IL-6 and G-
CSF production by vaginal ECs may affect neutrophil function in
vivo (once recruited by IL-8 and GM-CSF) resulting in detrimental
rather than beneficial effects and an associated high fungal burden.
Alternatively, the paucity of G-CSF and low IL-8 levels (compared
with oral ECs), may suggest lower levels of neutrophil recruitment
because they are detrimental vaginally or that vaginal ECs may
not be as effective as oral ECs in regulating the neutrophil-
mediated inflammatory response once initiated.
Of specific interest is CCL20, which recruits and activates CCR6-
expressing dendritic cells, B cells and T cell subsets [37,38]. The lack of
CCL20 production by vaginal ECs is likely to reduce the rate of
myeloid/lymphoid cell infiltration into vaginal tissues during C. albicans
infection, resulting in poor activation of cellular immunity that is a
typical feature of vaginal candidiasis [33]. Indeed, in a series of studies
in a mouse model of vaginal candidiasis, although dendritic cells do
infiltrate the vaginal mucosa, there is little or no evidence for dendritic
cell activation or T cell infiltration which is central to activation of
cellular immunity [33,39–41]. More detailed investigations are
required but the combined lack of IL-6, G-CSF and CCL20 secretion
by vaginal ECs may contribute to the differential immune responses
that are observed between oral and vaginal sites during C. albicans
infection. In addition, the differences between oral and vaginal data sets
may also be explained in part by the fact that vaginal ECs are at a
reproductive site and may have evolved to be more tolerant to
microbial pathogens and environmental stresses, thus inducing a
weaker immune response or at least fewer cytokines. Irrespective, the
combined features of C. albicans hypha formation/detection and
differential cytokine profiles between oral and vaginal ECs may be the
key processes that contribute to ‘immune compartmentalization’ at
these mucosal sites and thereby host protection, unresponsiveness or
susceptibility to superficial C. albicans infections.
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